Tempus AI (TEM) to Release Quarterly Earnings on Thursday

Tempus AI (NASDAQ:TEM - Get Free Report) is set to release its earnings data after the market closes on Thursday, November 7th. Analysts expect Tempus AI to post earnings of ($0.27) per share for the quarter. Tempus AI has set its FY 2024 guidance at EPS.Persons that wish to listen to the company's earnings conference call can do so using this link.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The business had revenue of $165.97 million for the quarter, compared to the consensus estimate of $159.10 million. On average, analysts expect Tempus AI to post $-7 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Tempus AI Trading Down 2.0 %

NASDAQ TEM traded down $0.89 during trading on Thursday, reaching $44.62. The company's stock had a trading volume of 603,618 shares, compared to its average volume of 1,112,055. The business's fifty day moving average is $51.47. The company has a debt-to-equity ratio of 4.50, a quick ratio of 3.52 and a current ratio of 3.70. Tempus AI has a twelve month low of $22.89 and a twelve month high of $77.00.

Analyst Ratings Changes

Several research analysts have weighed in on TEM shares. William Blair assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued an "outperform" rating for the company. Piper Sandler initiated coverage on Tempus AI in a report on Monday, August 12th. They set a "neutral" rating and a $40.00 price objective for the company. TD Cowen initiated coverage on Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $50.00 price target for the company. JPMorgan Chase & Co. upped their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a research report on Wednesday, August 7th. Finally, Loop Capital increased their price target on shares of Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research report on Tuesday, October 15th. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Tempus AI presently has a consensus rating of "Moderate Buy" and an average target price of $48.67.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.